Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
561 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07382791 | Delayed Gastric Emptying After Pancreatic Surgery | recruiting | — | 3,500 | National Taiwan University HospitalOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06557668 | Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer | recruiting | — | 250 | Taichung Veterans General HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07372300 | Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer(mEHT) | recruiting | Phase 3 | 126 | Shih-Kai HungOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06764355 | Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma(NICE-ESCC) | recruiting | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT06921837 | A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer | recruiting | Phase 1 / Phase 2 | 122 | Bolt Biotherapeutics, Inc.INDUSTRY | 3 | Jan 27, 2026 | clinicaltrials |
| NCT07365761 | Emotional Assessment and Tiered Individualized Psychological Support of the Artificial Intelligence Robot | recruiting | N/A | 130 | National Taiwan University HospitalOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | recruiting | Phase 3 | 892 | GlaxoSmithKlineINDUSTRY | 28 | Jan 23, 2026 | clinicaltrials |
| NCT03900910 | Gastric Cancer Prevention for Indigenous Peoples | recruiting | N/A | 50,000 | National Taiwan University HospitalOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT03237702 | Decipher Lethal Prostate Cancer Biology - Urine Metabolomics | recruiting | N/A | 2,000 | National Taiwan University HospitalOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT06908304 | A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC | recruiting | Phase 3 | 300 | Maia BiotechnologyINDUSTRY | 4 | Jan 12, 2026 | clinicaltrials |
| NCT07321470 | Complete vs. Postoperative Nasogastric Tube Omission in Pancreaticoduodenectomied Patients(PDNONG) | recruiting | N/A | 240 | National Taiwan University HospitalOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07241182 | Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy | recruiting | N/A | 40 | Tri-Service General Hospital (TSGH)OTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06235437 | Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141 | recruiting | Phase 1 | 21 | Ascendo Biotechnology Co., Ltd.INDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07322627 | ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients | recruiting | — | 700 | National Taiwan University HospitalOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07124117 | A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 147 | OBI Pharma, IncINDUSTRY | 2 | Jan 5, 2026 | clinicaltrials |
| NCT06366789 | Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia | recruiting | Phase 1 | 150 | Lomond Therapeutics Holdings, Inc.INDUSTRY | 4 | Dec 31, 2025 | clinicaltrials |
| NCT06027242 | Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy | recruiting | N/A | 120 | National Taiwan University HospitalOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06392477 | A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma | recruiting | Phase 1 | 96 | SanofiINDUSTRY | 5 | Dec 23, 2025 | clinicaltrials |
| NCT07298642 | Extended-field Proton Therapy for Cervical Cancer | recruiting | Phase 2 / Phase 3 | 44 | National Taiwan University HospitalOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07296250 | Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT | recruiting | N/A | 100 | Chang Gung Memorial HospitalOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT07294547 | Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study | recruiting | N/A | 80 | National Taiwan University HospitalOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT05317819 | Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma | recruiting | Phase 3 | 300 | Polaris GroupINDUSTRY | 2 | Dec 18, 2025 | clinicaltrials |
| NCT06478693 | A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC | recruiting | Phase 1 | 70 | Myeloid TherapeuticsINDUSTRY | 3 | Dec 18, 2025 | clinicaltrials |
| NCT07293013 | A Study on the Effectiveness of Olive Oil Mouthwash in Alleviating Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer. | recruiting | N/A | 120 | Chiayi Christian HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT06730009 | Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients | recruiting | Phase 1 / Phase 2 | 42 | Medigen Biotechnology CorporationINDUSTRY | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07237672 | AI Based Physiotherapy 3- and 9-Month Follow-Up in Oral Cancer Patients | recruiting | N/A | 65 | National Taiwan University HospitalOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07260370 | The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy | recruiting | — | 300 | Chang Gung Memorial HospitalOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT06632717 | Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma | recruiting | Phase 2 | 24 | National Taiwan University HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07232680 | Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy(IMPRINT) | recruiting | — | 500 | Cheng-En HsiehOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07244705 | A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC | recruiting | Phase 1 / Phase 2 | 66 | Anbogen Therapeutics, Inc.INDUSTRY | 2 | Nov 24, 2025 | clinicaltrials |
| NCT05914116 | A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 862 | DualityBio Inc.INDUSTRY | 4 | Nov 21, 2025 | clinicaltrials |
| NCT06560671 | Compare the Patient Satisfaction and Effectiveness After Novel Application-based or Conventional Health Education of Bowel Preparation for Colonoscopy | recruiting | N/A | 252 | National Taiwan University HospitalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07055594 | A Study to Investigate Safety and Preliminary Efficacy of SOA101 in Adult Subjects With Advanced Solid Tumors(NbTAST-01) | recruiting | Phase 1 / Phase 2 | 76 | Shine-On Biomedical Co., Ltd.INDUSTRY | 1 | Nov 6, 2025 | clinicaltrials |
| NCT04643418 | Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 81 | MegaPro Biomedical Co. Ltd.INDUSTRY | 1 | Nov 3, 2025 | clinicaltrials |
| NCT06174987 | A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) | recruiting | Phase 3 | 50 | Daiichi SankyoINDUSTRY | 12 | Oct 15, 2025 | clinicaltrials |
| NCT06699212 | A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases(ECLIPSE) | recruiting | Phase 3 | 412 | Rakuten Medical, Inc.INDUSTRY | 3 | Oct 15, 2025 | clinicaltrials |
| NCT05377034 | Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients(STRATUM) | recruiting | Phase 2 | 100 | National Cancer Centre, SingaporeOTHER | 4 | Oct 6, 2025 | clinicaltrials |
| NCT07209020 | HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery | recruiting | N/A | 60 | Maxigen Biotech Inc.INDUSTRY | 1 | Oct 6, 2025 | clinicaltrials |
| NCT07202611 | DC/NK Cell Therapy | recruiting | Phase 2 | 10 | National Taiwan University Clinical Trial CenterOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT07204574 | The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer | recruiting | Phase 1 / Phase 2 | 40 | Chang Gung Memorial HospitalOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06672250 | The Correlation Between Circulatory Tumor Cells and Venous Thrombosis | recruiting | — | 120 | Chang Gung Memorial HospitalOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT06531434 | Establishing Best Treatment Strategy for T4 Esophageal Cancer | recruiting | Phase 1 / Phase 2 | 22 | National Cheng-Kung University HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT04525833 | Liver Disease and Other Systemic Diseases | recruiting | — | 15,000 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT05541744 | The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer(NSCLC) | recruiting | — | 120 | Buddhist Tzu Chi General HospitalOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT07182214 | An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers. | recruiting | — | 1,340 | Pharus Taiwan, Inc.INDUSTRY | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06502275 | Nutrition and Exercise Program for Elderly Colorectal Cancer Patients | recruiting | N/A | 140 | Chang Gung University of Science and TechnologyOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07178093 | Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization | recruiting | N/A | 60 | Taichung Tzu Chi HospitalOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT05557487 | Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration(TRIO) | recruiting | — | 6,618 | Gee-Chen ChangOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT06999694 | Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC(Proton-STRIDE) | recruiting | Phase 2 | 45 | Chang Gung Memorial HospitalOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05622409 | A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma | recruiting | — | 250 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 8, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials